1. Home
  2. EARN vs AMRN Comparison

EARN vs AMRN Comparison

Compare EARN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.33

Market Cap

189.7M

Sector

Real Estate

ML Signal

HOLD

Logo Amarin Corporation plc

AMRN

Amarin Corporation plc

HOLD

Current Price

$14.14

Market Cap

339.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
AMRN
Founded
2012
1989
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
339.8M
IPO Year
2013
1993

Fundamental Metrics

Financial Performance
Metric
EARN
AMRN
Price
$5.33
$14.14
Analyst Decision
Buy
Strong Sell
Analyst Count
2
1
Target Price
$5.88
$12.00
AVG Volume (30 Days)
309.1K
87.4K
Earning Date
02-20-2026
10-29-2025
Dividend Yield
18.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,893,000.00
$226,733,000.00
Revenue This Year
$8.43
N/A
Revenue Next Year
$17.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.30
N/A
52 Week Low
$4.33
$7.08
52 Week High
$6.86
$20.90

Technical Indicators

Market Signals
Indicator
EARN
AMRN
Relative Strength Index (RSI) 55.68 41.21
Support Level $5.15 $13.50
Resistance Level $5.35 $14.30
Average True Range (ATR) 0.10 0.75
MACD 0.01 -0.00
Stochastic Oscillator 81.67 25.43

Price Performance

Historical Comparison
EARN
AMRN

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: